Provided by Tiger Trade Technology Pte. Ltd.

Tonix Pharmaceuticals

9.23
-0.5100-5.24%
Volume:397.10K
Turnover:3.73M
Market Cap:158.30M
PE:-0.74
High:9.69
Open:9.65
Low:9.21
Close:9.74
52wk High:25.50
52wk Low:9.21
Shares:17.15M
Float Shares:14.99M
Volume Ratio:0.98
T/O Rate:2.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.4882
EPS(LYR):-14.5713
ROE:-81.82%
ROA:-46.84%
PB:0.71
PE(LYR):-0.63

Loading ...

Tonix Pharmaceuticals Announces Publication of Phase 1 Clinical Data of TNX-1500, an Fc-Modified anti-CD40L (CD154) Monoclonal Antibody, in the Peer-Reviewed Journal of Clinical Immunology

GlobeNewswire
·
May 27

Tonix Pharmaceuticals publishes investor deck highlighting TONMYA fibromyalgia launch strategy

Reuters
·
May 27

Analysts Offer Insights on Healthcare Companies: Daxor (DXR) and Tonix Pharma (TNXP)

TIPRANKS
·
May 26

Tonix Pharmaceuticals presents data from analysis of adults with fibromyalgia

TIPRANKS
·
May 26

Tonix presents real-world U.S. claims analysis of 261,776 fibromyalgia patients at ISPOR 2026

Reuters
·
May 26

Press Release: Tonix Pharmaceuticals Presented Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at The Professional Society for Health Economics and Outcomes Research (ISPOR) 2026 Annual Meeting

Dow Jones
·
May 26

Tonix Pharmaceuticals posts TNX-4800 Lyme disease prevention presentation

Reuters
·
May 18

Tonix publishes TNX-1500 xenotransplantation workshop presentation

Reuters
·
May 18

Analysts Offer Insights on Healthcare Companies: Veracyte (VCYT), Tonix Pharma (TNXP) and Regeneron (REGN)

TIPRANKS
·
May 18

Tonix publishes investor deck highlighting TONMYA fibromyalgia launch strategy

Reuters
·
May 15

Tonix Pharmaceuticals to Present Retrospective U.S. Real-World Claims Analysis Characterizing Patients with Fibromyalgia at ISPOR 2026

GlobeNewswire
·
May 14

Tonix Pharmaceuticals to present at RBC Capital Markets Global Healthcare Conference

Reuters
·
May 13

Tonix Pharmaceuticals to Participate in Two Investor Conferences in May

GlobeNewswire
·
May 13

Analysts’ Top Healthcare Picks: Dexcom (DXCM), Tonix Pharma (TNXP)

TIPRANKS
·
May 12

Tonix Pharmaceuticals reports Q1 EPS ($2.93) vs. ($2.84) last year

TIPRANKS
·
May 12

Tonix Pharmaceuticals Holding Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Tonix Pharmaceuticals Q1 EPS $(2.93) Misses $(2.43) Estimate, Sales $6.878M Beat $6.100M Estimate

Benzinga Earnings
·
May 12

Tonix Q1 FY26 net loss widens to $40.2 million; net product revenue rises to $6.9 million

Reuters
·
May 12

Tonix Pharmaceuticals: Expect to Begin Phase 2 Study of Tonmya for Treatment of Major Depressive Disorder (Mdd) Mid-Year

THOMSON REUTERS
·
May 12

Tonix Pharmaceuticals: to Initiate Adaptive Phase 2 Field Study for Prevention of Lyme Disease in U.S. in H1 2027 for Tnx-4800, Pending FDA Agreement

THOMSON REUTERS
·
May 12